Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine

This potentially life-threatening disease poses an interesting perspective on adverse events that can occur or can be exacerbated following the Ad26.COV2.S (Johnson & Johnson) vaccine. The authors report findings in a 65-year-old female patient who experienced facial diplegia, an atypical varian...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Esha, Pandav, Krunal, Regmi, Pratima, Michel, George, Altshuler, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381448/
https://www.ncbi.nlm.nih.gov/pubmed/34447646
http://dx.doi.org/10.7759/cureus.16612
_version_ 1783741370034290688
author Jain, Esha
Pandav, Krunal
Regmi, Pratima
Michel, George
Altshuler, Ida
author_facet Jain, Esha
Pandav, Krunal
Regmi, Pratima
Michel, George
Altshuler, Ida
author_sort Jain, Esha
collection PubMed
description This potentially life-threatening disease poses an interesting perspective on adverse events that can occur or can be exacerbated following the Ad26.COV2.S (Johnson & Johnson) vaccine. The authors report findings in a 65-year-old female patient who experienced facial diplegia, an atypical variant of Guillain-Barré syndrome, two weeks after receiving the Ad26.COV2.S vaccine against coronavirus disease 2019. Post-approval pharmacovigilance of each vaccine helps better understand the long-term outcomes, and reporting adverse events is crucial for advancements in medical knowledge. 
format Online
Article
Text
id pubmed-8381448
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83814482021-08-25 Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine Jain, Esha Pandav, Krunal Regmi, Pratima Michel, George Altshuler, Ida Cureus Emergency Medicine This potentially life-threatening disease poses an interesting perspective on adverse events that can occur or can be exacerbated following the Ad26.COV2.S (Johnson & Johnson) vaccine. The authors report findings in a 65-year-old female patient who experienced facial diplegia, an atypical variant of Guillain-Barré syndrome, two weeks after receiving the Ad26.COV2.S vaccine against coronavirus disease 2019. Post-approval pharmacovigilance of each vaccine helps better understand the long-term outcomes, and reporting adverse events is crucial for advancements in medical knowledge.  Cureus 2021-07-25 /pmc/articles/PMC8381448/ /pubmed/34447646 http://dx.doi.org/10.7759/cureus.16612 Text en Copyright © 2021, Jain et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Jain, Esha
Pandav, Krunal
Regmi, Pratima
Michel, George
Altshuler, Ida
Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
title Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
title_full Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
title_fullStr Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
title_full_unstemmed Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
title_short Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
title_sort facial diplegia: a rare, atypical variant of guillain-barré syndrome and ad26.cov2.s vaccine
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381448/
https://www.ncbi.nlm.nih.gov/pubmed/34447646
http://dx.doi.org/10.7759/cureus.16612
work_keys_str_mv AT jainesha facialdiplegiaarareatypicalvariantofguillainbarresyndromeandad26cov2svaccine
AT pandavkrunal facialdiplegiaarareatypicalvariantofguillainbarresyndromeandad26cov2svaccine
AT regmipratima facialdiplegiaarareatypicalvariantofguillainbarresyndromeandad26cov2svaccine
AT michelgeorge facialdiplegiaarareatypicalvariantofguillainbarresyndromeandad26cov2svaccine
AT altshulerida facialdiplegiaarareatypicalvariantofguillainbarresyndromeandad26cov2svaccine

Ejemplares similares